Experimental Alzheimer's Drug Slows Cognitive Decline By 38% In A Two-Year Trial: How Does It Work?

Experimental Alzheimer's Drug Slows Cognitive Decline By 38% In A Two-Year Trial: How Does It Work?

Credit: AI image

Text

Updated Nov 18, 2026 | 09:00 PM IST

SummaryBiogen's investigational Alzheimer's drug, injected 60 mg in the spinal cord, showed significant outcomes in slowing down cognitive decline linked with the disease.

End of Article